<![CDATA[FDA OKs Subcutaneous Daratumumab in High-Risk Smoldering Multiple Myeloma]]> Cancer Network | November 6, 2025 Topics: blood-cancer Read the full article at Cancer Network Back to Latest Cancer Research | Our Sources | Subscribe to Newsletter